A pharmaceutical company had fallen short of savings targets for several years in a row while preparing for sale. Now the new PE owners wanted to accelerate cost savings, reduce inventory, and improve financial health. And they wanted to be sure the cost savings from their accelerated value creation program would also be sustainable long-term.
The company had issues with procurement, integrated business supply planning (IBP), and logistics. These included supply disruptions, noncompetitive costs, and margin erosion on third-party partnerships. For example, they were paying suppliers about 24% more than their competitors, creating a large competition and market gap.
SGS Maine Pointe: